NASDAQ:MACK   Merrimack Pharmaceuticals, Inc.
0
Broke the .236 retracement and soon to re-test $6.50. Bullish crosses on 50,100,200. Trial update in Q2 for Phase 3 MM-398. Position: 4,200 shares @4.82
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.